SCHEMBL28524580

SCHEMBL28524580

CC1(C)c2c(Br)ccc(C(=O)Nc3ccc(OC(F)(F)Cl)cc3)c2C(=O)N1CCO

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 17/20 0.41
▸ FLT1 P17948 2/20 0.38
▸ KDR P35968 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28526329 0.82 ABL1 (0.49) ABL1
SCHEMBL30046660 0.72 ABL1 (0.59) ABL1
SCHEMBL22939371 0.72 ABL1 (0.59) ABL1
SCHEMBL30046925 0.72 ABL1 (0.53) ABL1
SCHEMBL22939415 0.72 ABL1 (0.53) ABL1
SCHEMBL22939435 0.71 ABL1 (0.49) ABL1
SCHEMBL30046697 0.71 ABL1 (0.49) ABL1
SCHEMBL28518670 0.71 ABL1 (0.46) ABL1
SCHEMBL28525027 0.71 ABL1 (0.48) ABL1
SCHEMBL22938434 0.67 ABL1 (0.52) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112300129-B Heterocyclic compounds as BCR-ABL inhibitors 苏州亚盛药业有限公司 2021-09-14 — — CN disclosed
CN-112300129-A Heterocyclic compounds as BCR-ABL inhibitors 苏州亚盛药业有限公司 2021-02-02 — — CN disclosed
Send feedback